Literature DB >> 27590339

Role of the Conserved Disulfide Bridge in Class A Carbapenemases.

Clyde A Smith1, Zahra Nossoni2, Marta Toth2, Nichole K Stewart2, Hilary Frase2, Sergei B Vakulenko3.   

Abstract

Some members of the class A β-lactamase family are capable of conferring resistance to the last resort antibiotics, carbapenems. A unique structural feature of these clinically important enzymes, collectively referred to as class A carbapenemases, is a disulfide bridge between invariant Cys69 and Cys238 residues. It was proposed that this conserved disulfide bridge is responsible for their carbapenemase activity, but this has not yet been validated. Here we show that disruption of the disulfide bridge in the GES-5 carbapenemase by the C69G substitution results in only minor decreases in the conferred levels of resistance to the carbapenem imipenem and other β-lactams. Kinetic and circular dichroism experiments with C69G-GES-5 demonstrate that this small drop in antibiotic resistance is due to a decline in the enzyme activity caused by a marginal loss of its thermal stability. The atomic resolution crystal structure of C69G-GES-5 shows that two domains of this disulfide bridge-deficient enzyme are held together by an intensive hydrogen-bonding network. As a result, the protein architecture and imipenem binding mode remain unchanged. In contrast, the corresponding hydrogen-bonding networks in NMCA, SFC-1, and SME-1 carbapenemases are less intensive, and as a consequence, disruption of the disulfide bridge in these enzymes destabilizes them, which causes arrest of bacterial growth. Our results demonstrate that the disulfide bridge is essential for stability but does not play a direct role in the carbapenemase activity of the GES family of β-lactamases. This would likely apply to all other class A carbapenemases given the high degree of their structural similarity.
© 2016 by The American Society for Biochemistry and Molecular Biology, Inc.

Entities:  

Keywords:  antibiotic resistance; carbapenemase; crystal structure; disulfide; enzyme kinetics; enzyme stability; hydrogen bond

Mesh:

Substances:

Year:  2016        PMID: 27590339      PMCID: PMC5063999          DOI: 10.1074/jbc.M116.749648

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  38 in total

1.  The Protein Data Bank.

Authors:  H M Berman; J Westbrook; Z Feng; G Gilliland; T N Bhat; H Weissig; I N Shindyalov; P E Bourne
Journal:  Nucleic Acids Res       Date:  2000-01-01       Impact factor: 16.971

2.  Using circular dichroism spectra to estimate protein secondary structure.

Authors:  Norma J Greenfield
Journal:  Nat Protoc       Date:  2006       Impact factor: 13.491

Review 3.  Proliferation and significance of clinically relevant β-lactamases.

Authors:  Karen Bush
Journal:  Ann N Y Acad Sci       Date:  2013-01       Impact factor: 5.691

4.  ampC cephalosporinase of Escherichia coli K-12 has a different evolutionary origin from that of beta-lactamases of the penicillinase type.

Authors:  B Jaurin; T Grundström
Journal:  Proc Natl Acad Sci U S A       Date:  1981-08       Impact factor: 11.205

5.  Structural basis for progression toward the carbapenemase activity in the GES family of β-lactamases.

Authors:  Clyde A Smith; Hilary Frase; Marta Toth; Malika Kumarasiri; Kwame Wiafe; Jared Munoz; Shahriar Mobashery; Sergei B Vakulenko
Journal:  J Am Chem Soc       Date:  2012-11-16       Impact factor: 15.419

6.  Structure of GES-1 at atomic resolution: insights into the evolution of carbapenamase activity in the class A extended-spectrum beta-lactamases.

Authors:  Clyde A Smith; Marisa Caccamo; Katherine A Kantardjieff; Sergei Vakulenko
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2007-08-17

7.  Site-directed mutagenesis at the active site of Escherichia coli TEM-1 beta-lactamase. Suicide inhibitor-resistant mutants reveal the role of arginine 244 and methionine 69 in catalysis.

Authors:  M Delaire; R Labia; J P Samama; J M Masson
Journal:  J Biol Chem       Date:  1992-10-15       Impact factor: 5.157

Review 8.  Class A carbapenemases.

Authors:  Jan Walther-Rasmussen; Niels Høiby
Journal:  J Antimicrob Chemother       Date:  2007-06-26       Impact factor: 5.790

9.  Mechanistic basis for the emergence of catalytic competence against carbapenem antibiotics by the GES family of beta-lactamases.

Authors:  Hilary Frase; Qicun Shi; Sebastian A Testero; Shahriar Mobashery; Sergei B Vakulenko
Journal:  J Biol Chem       Date:  2009-08-05       Impact factor: 5.157

10.  How good are my data and what is the resolution?

Authors:  Philip R Evans; Garib N Murshudov
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2013-06-13
View more
  13 in total

1.  First virtual screening and experimental validation of inhibitors targeting GES-5 carbapenemase.

Authors:  Francesca Spyrakis; Pierangelo Bellio; Antonio Quotadamo; Pasquale Linciano; Paolo Benedetti; Giulia D'Arrigo; Massimo Baroni; Laura Cendron; Giuseppe Celenza; Donatella Tondi
Journal:  J Comput Aided Mol Des       Date:  2019-01-02       Impact factor: 3.686

2.  P174E Substitution in GES-1 and GES-5 β-Lactamases Improves Catalytic Efficiency toward Carbapenems.

Authors:  Alessandra Piccirilli; Paola Sandra Mercuri; Moreno Galleni; Massimiliano Aschi; André Matagne; Gianfranco Amicosante; Mariagrazia Perilli
Journal:  Antimicrob Agents Chemother       Date:  2018-04-26       Impact factor: 5.191

3.  Molecular Basis for the Potent Inhibition of the Emerging Carbapenemase VCC-1 by Avibactam.

Authors:  Chand S Mangat; Grishma Vadlamani; Viktor Holicek; Mitchell Chu; Veronica L C Larmour; David J Vocadlo; Michael R Mulvey; Brian L Mark
Journal:  Antimicrob Agents Chemother       Date:  2019-03-27       Impact factor: 5.191

4.  Penicillanic Acid Sulfones Inactivate the Extended-Spectrum β-Lactamase CTX-M-15 through Formation of a Serine-Lysine Cross-Link: an Alternative Mechanism of β-Lactamase Inhibition.

Authors:  Philip Hinchliffe; Catherine L Tooke; Christopher R Bethel; Benlian Wang; Christopher Arthur; Kate J Heesom; Stuart Shapiro; Daniela M Schlatzer; Krisztina M Papp-Wallace; Robert A Bonomo; James Spencer
Journal:  mBio       Date:  2022-05-25       Impact factor: 7.786

5.  Structural Basis and Binding Kinetics of Vaborbactam in Class A β-Lactamase Inhibition.

Authors:  Orville A Pemberton; Ruslan Tsivkovski; Maxim Totrov; Olga Lomovskaya; Yu Chen
Journal:  Antimicrob Agents Chemother       Date:  2020-09-21       Impact factor: 5.191

6.  Proteomic identification of Axc, a novel beta-lactamase with carbapenemase activity in a meropenem-resistant clinical isolate of Achromobacter xylosoxidans.

Authors:  Frank Fleurbaaij; Alex A Henneman; Jeroen Corver; Cornelis W Knetsch; Wiep Klaas Smits; Sjoerd T Nauta; Martin Giera; Irina Dragan; Nitin Kumar; Trevor D Lawley; Aswin Verhoeven; Hans C van Leeuwen; Ed J Kuijper; Paul J Hensbergen
Journal:  Sci Rep       Date:  2018-05-25       Impact factor: 4.379

Review 7.  β-Lactamases and β-Lactamase Inhibitors in the 21st Century.

Authors:  Catherine L Tooke; Philip Hinchliffe; Eilis C Bragginton; Charlotte K Colenso; Viivi H A Hirvonen; Yuiko Takebayashi; James Spencer
Journal:  J Mol Biol       Date:  2019-04-05       Impact factor: 5.469

8.  Targeting the Class A Carbapenemase GES-5 via Virtual Screening.

Authors:  Raphael Klein; Laura Cendron; Martina Montanari; Pierangelo Bellio; Giuseppe Celenza; Lorenzo Maso; Donatella Tondi; Ruth Brenk
Journal:  Biomolecules       Date:  2020-02-14

Review 9.  Molecular Mechanisms, Epidemiology, and Clinical Importance of β-Lactam Resistance in Enterobacteriaceae.

Authors:  Giulia De Angelis; Paola Del Giacomo; Brunella Posteraro; Maurizio Sanguinetti; Mario Tumbarello
Journal:  Int J Mol Sci       Date:  2020-07-18       Impact factor: 5.923

10.  New Strategy for the Immobilization of Lipases on Glyoxyl-Agarose Supports: Production of Robust Biocatalysts for Natural Oil Transformation.

Authors:  César A Godoy
Journal:  Int J Mol Sci       Date:  2017-10-12       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.